The Role of PARP Inhibitors in Advanced Prostate Cancer (2023)

PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to TestПодробнее

PARPi: Precision Medicine in Advanced Prostate CancerПодробнее

The Role of PARP Inhibitors in Advanced Prostate CancerПодробнее

The Changing Face of Advanced Prostate Cancer (2024)Подробнее

Prostate Cancer | Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor...Подробнее

PARPi: Management of Adverse Events (2024)Подробнее

PARPi: Precision Medicine in Advanced Prostate Cancer (2023)Подробнее

PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test (2023)Подробнее

PARP inhibitors in advanced prostate cancerПодробнее

Advanced #ProstateCancer Treatments | Eugene Kwon, MD | DIY Combat Manual | Part 5 #PCRIПодробнее

Acting on Actionable Mutations: Genetic Testing and PARP Inhibitors for Advanced Prostate CancerПодробнее

New FDA Approved PARP Inhibitor: Talzenna (Talazoparib) & Xtandi | #markscholzmd #AlexScholz #pcriПодробнее

Webinar: Parp-Inhibitors and Prostate Cancer - Gotta Have a Mutation??? 06/29/2023Подробнее

AUA Guidelines on Advanced Prostate Cancer Webcast (2023)Подробнее

Live from AUA2023: Highlights in Advanced Prostate CancerПодробнее

PARP Inhibitors & Advanced Prostate CancerПодробнее

Treatment Updates for Advanced Prostate Cancer – 2023 ZERO Prostate Cancer SummitПодробнее

PARP Inhibitors in Advanced Prostate Cancer CareПодробнее

The Role of Genetic Testing and PARP Inhibitors (2022)Подробнее